LN Future Invest AB, formerly Ellen AB, is a Sweden-based biotechnology company that produces probiotic sanitary protection products for women. The Companyâ€™s main product, Ellen tampon, contains patented natural lacto acid bacteria, Lacto Naturel (LN), and is used for maintaining the vaginal health. The Ellen tampon is made of natural fibers treated with the substance LN, which consists of human lactic acid bacteria, a natural part of healthy women's defense against infections. Ellen AB distributes its products in 37 countries, including Scandinavian countries, France, Germany, Czech Republic, Spain, Portugal, Poland and Belgium, among others.

Employees

Sector

Personal Products

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Stockholm 10:30:00 23/02/2026 pm IST			5-day change	1st Jan Change
0.9250 ^SEK	+6.94%		-.--%	+10.78%

25/02	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
16/02	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI

Market Cap	1.02Cr 10.78L 9L 9L 8L 14.93L 10Cr 14.98L 40.02L 5.19Cr 40.47L 39.59L 17Cr	P/E 2024	-8.92x	P/E 2025	1.23x
Enterprise Value	-24.38L -3L -2L -2L -2L -4L -2.45Cr -4L -10L -1.24Cr -10L -9L -4.12Cr	EV / Sales 2024	0.37x	EV / Sales 2025	-0.24x
Free-Float	39.6%	Yield 2024 *	-	Yield 2025	75.4%

25/02	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
16/02	LN Future Invest AB announces Annual dividend, payable on March 25, 2026	CI
26/01	LN Future Invest to Be Delisted from First North, Last Trading Day Set for February 23	FW
26/01	Nasdaq Stockholm to delist LN Future Invest shares on Feb 23	RE
04/25/04	Ln Future Invest begins work on reverse acquisition opportunities	RE
29/25/29	Ln Future Invest H1 net sales at SEK 11.3 mln	RE
29/25/29	LN Future Invest AB Reports Earnings Results for the Half Year Ended June 30, 2025	CI
20/25/20	Ellen Completes Business Transfer to Addeira Pharmaceuticals	FW
10/25/10	Ellen enters into conditional agreement to sell business	RE
09/25/09	Addeira Pharmaceuticals Ab agreed to acquire Business of Ellen AB from Ellen AB (OM:ELN) for SEK 13.3 million.	CI
27/25/27	Ellen Q1 EBITDA Falls To SEK 102,000	RE
28/25/28	Ellen H2 EBIT Loss SEK 1 Mln	RE
28/25/28	LN Future Invest AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI

1 day	+6.94%
Current year	+10.78%

Ellen AB Share Price

Stocks

LNFI

SE0014730347

Personal Products

Valuation : Ellen AB

Chart: Ellen AB

Latest news : Ellen AB

Press Releases : Ellen AB

Quotes and Performance

Price Extremes

Managers and Directors : Ellen AB

Sanitary Products

Financials

Company Profile

Current year	0.75	0.92
1 year	0.58	1.35
3 years	0.49	2
5 years	0.49	7.58
10 years	0.49	79

Manager	Title	Age	Since
Sofia Fredrikson CEO	Chief Executive Officer	43	-
Sven Olof Mattsson IRC	Investor Relations Contact	65	01/05/2021
Lena De Wall ADM	Chief Administrative Officer	-	-

Director	Title	Age	Since
Jan Fredrik Mikael Lövgren BRD	Director/Board Member	65	09/07/2004
Sven Olof Mattsson CHM	Chairman	65	01/01/2025
Sofia Fredrikson BRD	Director/Board Member	43	18/09/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELLEN AB	+6.94%	-.--%	-17.41%	-22.92%	11.03L
KIMBERLY-CLARK CORPORATION	-0.33%	+0.09%	-15.28%	-14.88%	3.67TCr
UNICHARM CORPORATION	-1.01%	+0.22%	+0.79%	-48.28%	1.07TCr
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	-1.33%	-7.88%	-11.12%	-24.55%	331.91Cr
SOFTCARE LIMITED	-2.12%	+1.13%	-	-	260.64Cr
GILLETTE INDIA LIMITED	+0.05%	-1.34%	-25.86%	+34.05%	252.86Cr
C&S PAPER CO.,LTD	+1.14%	-0.70%	-19.37%	-29.08%	135.45Cr
OIL-DRI CORPORATION OF AMERICA	+1.15%	-1.09%	+55.41%	+170.53%	131.09Cr
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	+1.05%	-0.30%	-52.63%	-0.66%	87Cr
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	+2.99%	+4.23%	-38.34%	-13.52%	81Cr
Average	+0.85%	+0.88%	-13.76%	+5.63%	602.23Cr
Weighted average by Cap.	-0.44%	+1.86%	-11.89%	-15.39%

	2024	2025
Net sales	2.35Cr 24.7L 21.18L 19.87L 18.16L 34.2L 24Cr 34.32L 91.7L 12Cr 92.73L 90.72L 40Cr	1.41Cr 14.88L 12.76L 11.97L 10.94L 20.61L 14Cr 20.68L 55.25L 7.17Cr 55.87L 54.65L 24Cr
Net income	-12.42L -1L -1L -1L -96.07T -2L -1.25Cr -2L -5L -62.95L -5L -5L -2.1Cr	75.07L 8L 7L 6L 6L 10.94L 7.54Cr 10.97L 29.32L 3.8Cr 29.65L 29L 13Cr
Net Debt	-24.26L -3L -2L -2L -2L -4L -2.44Cr -4L -9L -1.23Cr -10L -9L -4.1Cr	-1.27Cr -13.35L -11.44L -10.74L -10L -18.48L -13Cr -18.54L -49.55L -6.43Cr -50.1L -49.01L -21Cr